Faeth Therapeutics, Inc. - 8-K Filing
Faeth Therapeutics reports positive topline Phase 2 results for PIKTOR in advanced endometrial cancer, supporting advancement to Phase 3 trial. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)